Feb 1, 2022 Mydecine submits pre-IND briefing package to FDA for MYCO-001 smoking cessation clinical trial
Jan 6, 2022 The Future of Psilocybin Therapy with Josh Bartch, CEO of Mydecine Innovation Group on Gamechangers®